Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Melissa La Mar"'
Autor:
Mansi Saxena, Rachel L. Sabado, Melissa La Mar, Hiroshi Mohri, Andres M. Salazar, Hanqing Dong, Joel Correa Da Rosa, Martin Markowitz, Nina Bhardwaj, Elizabeth Miller
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Objective: Toll-like receptor-3 agonist Poly-ICLC has been known to activate immune cells and induce HIV replication in pre-clinical experiments. In this study we investigated if Poly-ICLC could be used for disrupting HIV latency while simultaneously
Externí odkaz:
https://doaj.org/article/8882ec04a6a34d43ab8b7793ad5b0f59
Autor:
Debora Dunbar, Kristina Rodriguez, Kathrine Meyers, Magdalena E. Sobieszczyk, David Margolis, Beryl A. Koblin, Ian Frank, Hong Van Tieu, Melissa La Mar, Yumeng Wu, Atrina L. Brill, Martin Markowitz, Sarit A. Golub
Publikováno v:
AIDS and Behavior. 22:1209-1216
This study aimed to identify patients' physical and psychosocial experiences of an investigational long-acting injectable PrEP product to aid in the development of patient and provider education materials. Twenty-eight participants of a Phase 2 safet
Autor:
Hiroshi Mohri, Rachel Lubong Sabado, Hanqing Dong, Melissa La Mar, Elizabeth M. Miller, Mansi Saxena, Martin Markowitz, Nina Bhardwaj, Andres M. Salazar, Joel Correa da Rosa
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology, Vol 10 (2019)
Objective: Toll-like receptor-3 agonist Poly-ICLC has been known to activate immune cells and induce HIV replication in pre-clinical experiments. In this study we investigated if Poly-ICLC could be used for disrupting HIV latency while simultaneously
Autor:
Teresa H. Evering, Evelyn Silva, Kristina Rodriguez, Charles M. Cleland, Melissa La Mar, Natanya Gettie, Pedro Batista, Sherry Deren, Saurabh Mehandru, Martin Markowitz, Haekyung Lee, Leslie St. Bernard
Background. Chronic inflammation, as defined by persistent immune activation, is associated with adverse clinical outcomes. People who inject drugs (PWID) have evidence of persistent immune activation. Here, in a cohort of PWID with or without hepati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04de97cb9c0d2b52410a881fb1f29e93
https://europepmc.org/articles/PMC5079368/
https://europepmc.org/articles/PMC5079368/
Autor:
Donald Garmon, David M. Dorfman, Martin Markowitz, Allison J. Applebaum, Teresa H. Evering, Melissa La Mar
Publikováno v:
AIDS (London, England). 30(2)
Objective: To determine the prevalence of HIV-associated neurocognitive disorders (HAND) in HIV-infected participants who initiated combination antiretroviral therapy (cART) during primary infection. Design: Cross-sectional observational study. Metho
Autor:
Kristina Rodriguez, Teresa H. Evering, Nicole Prada, Hiroshi Mohri, Vincent Sahi, Sarah Palmer, Martin Markowitz, Marina Caskey, Donald Garmon, Melissa La Mar
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 66(2)
BACKGROUND To understand whether combination antiretroviral therapy (cART) has been optimized, we asked whether 3-drug protease inhibitor (PI)-based cART intensified with raltegravir and maraviroc and initiated during early infection would improve ou
Autor:
Leslie Berry, Melissa La Mar, Michael P. Mullen, Anita Shet, Amir Horowitz, Neil Parkin, Hiroshi Mohri, Chris Chung, Alexandria Kim, Saurabh Mehandru, Michael A. Poles, Roopa Kalyanaraman, David D. Ho, Patrick Jean-Pierre, Terri Wrin, Daniel Boden, Christos J. Petropoulos, Martin Markowitz
Publikováno v:
Lancet (London, England). 365(9464)
Summary Background Rapid progression to AIDS after acute HIV-1 infection, though uncommon, has been noted, as has the transmission of multidrug resistant viruses. Here, we describe a patient in whom these two factors arose concomitantly and assess th